Concord Drugs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	7.51	2.25	1.76	0.99	0.65
Cash & Short-Term Investments	7.51	2.25	1.76	0.99	0.65
Cash Growth	232.96%	27.78%	77.46%	51.99%	15.81%
Accounts Receivable	243.82	136.05	127.29	158.1	228.59
Receivables	243.82	136.05	127.29	158.1	228.59
Inventory	255.16	252.69	229.23	200.65	174.9
Other Current Assets	26.64	16.63	16.89	74.82	14.77
Total Current Assets	533.12	407.62	375.18	434.56	418.91
Property, Plant & Equipment	133.69	135.69	126.67	132.04	138.83
Long-Term Investments	7.83	8	8.41	8.94	-
Long-Term Accounts Receivable	-	92.93	70.97	-	-
Other Long-Term Assets	74.25	7.19	6.84	6.77	6.71
Total Assets	748.88	651.42	588.06	582.31	564.45
Accounts Payable	70.71	76.22	31.01	52.72	71.79
Accrued Expenses	-	2.42	5.37	6.17	8.81
Short-Term Debt	117.93	158.68	159.49	142.26	139.52
Current Portion of Long-Term Debt	-	20.51	9.25	8.27	7.88
Current Income Taxes Payable	4.13	2.06	2.23	3.81	6.71
Other Current Liabilities	17.9	1.91	2.7	2.91	1.77
Total Current Liabilities	210.68	261.8	210.05	216.15	236.47
Long-Term Debt	18.06	13.24	6.45	19.11	16.95
Pension & Post-Retirement Benefits	-	7.6	5.7	4.75	0.95
Long-Term Deferred Tax Liabilities	6.24	6.26	4.73	5.37	6.59
Other Long-Term Liabilities	28.76	21.38	22.95	19.89	19.89
Total Liabilities	263.74	310.28	249.89	265.27	280.85
Common Stock	131.75	100	100	93.16	87.44
Additional Paid-In Capital	-	85.89	85.89	70.15	57
Retained Earnings	-	151.14	148.19	143.99	135.07
Comprehensive Income & Other	353.39	4.1	4.1	9.75	4.1
Shareholders' Equity	485.14	341.14	338.18	317.04	283.61
Total Liabilities & Equity	748.88	651.42	588.06	582.31	564.45
Total Debt	135.99	192.44	175.19	169.65	164.34
Net Cash (Debt)	-128.49	-190.18	-173.42	-168.65	-163.69
Net Cash Per Share	-11.57	-19.02	-17.34	-18.11	-18.72
Filing Date Shares Outstanding	4.9	10	10	8.74	8.74
Total Common Shares Outstanding	4.9	10	10	8.74	8.74
Working Capital	322.44	145.82	165.13	218.42	182.44
Book Value Per Share	98.94	34.11	33.82	36.26	32.44
Tangible Book Value	485.14	341.14	338.18	317.04	283.61
Tangible Book Value Per Share	98.94	34.11	33.82	36.26	32.44
Buildings	-	-	-	-	67.6
Machinery	-	-	-	-	297.22
Construction In Progress	-	-	-	-	5.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.